Document is current
Any future updates will be listed below
-
Authors
Murasaki, Mitsukuni
Inoue, Yoshifumi
Nakamura, Hiroshi http://orcid.org/0000-0001-7699-9840
Kinoshita, Toshihiko
-
Funding
Funding for this research was provided by:
Sumitomo Dainippon Pharma co, Ltd
- License Information
-
More Information
Article History
Received: 2 January 2021
Accepted: 8 August 2021
First Online: 7 September 2021
Declarations
:
: The study protocols of the two studies included in this review were approved by the institutional review board at each study site. Written informed consent was obtained from all participants.
: Not applicable.
: MM reports personal fees from Meiji Seika Pharma, Otsuka pharma, Shionogi Pharma, Sumitomo Dainippon Pharma, Eli Lilly, Pfizer, Janssen, and Astellas, outside the submitted work.HN and YI are the employees of Sumitomo Dainippon Pharma Co., Ltd.TK reports personal fees from Otsuka, Janssen, Sumitomo Dainippon Pharma, Meiji Seika Pharma, Eisai, Daiichi Sankyo, Merck Sharp & Dohme, and FUJIFILM Toyama Pharmaceutical; other from Sumitomo Dainippon Pharma, HISAMITSU PHARMACEUTICAL, and Takeda Pharmaceutical, outside the submitted work.
